Inhibition of interleukin ‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?

Experimental Dermatology,Volume 27, Issue 7, Page 737-747, July 2018.

Source: Experimental Dermatology - June 28, 2018 Category: Dermatology Authors: Elizabeth N. Ergen , Nabiha Yusuf Source Type: research